Moderna (MRNA) closed at $34.01 in the latest trading session, marking a -1.9% move from the prior day. This change lagged the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.7%, and the ...

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Exelixis. The consensus rating ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Moderna stock is indeed in the doldrums today, but this offers the opportunity to buy at a reasonable price, and, 10 years down the road, potentially benefit from a huge biotech growth story.

Even though RGTI stock has already seen an impressive 1,300% increase over the past twelve months, the question persists: ...

Thursday, July 24, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems ...

The S&P 500 and the Nasdaq Composite ended Thursday's session with fresh record closes after scoring new all-time intraday ...

The S&P 500 ticked 0.1% on Monday, July 14, 2025, as trade policy remained in the spotlight to kick off a week that also ...

The S&P 500 slid 0.3% on Friday, July 11, 2025, retreating from record levels after President Trump announced a 35% tariff on ...